Treatment with rituximab in idiopathic membranous nephropathy

Conclusions
The present study confirmed that treatment with rituximab was remarkably safe and allowed for a large percentage of complete or partial remissions in patients with MN.

Source: CKJ: Clinical Kidney Journal - December 16, 2016 Category: Urology & Nephrology Authors: Fiorentino, M., Tondolo, F., Bruno, F., Infante, B., Grandaliano, G., Gesualdo, L., Manno, C. Tags: GLOMERULOPATHIES Source Type: research